As shown in Fig. 1F, G, we found that glycolysis/gluconeogenesis, signaling by ERBB2, cellular response to chemical stress, MAPK activation, and extracellular matrix organization pathways were enriched in the plasma samples of CRC patients. The gene discussed is ERBB2; the disease is colorectal carcinoma.